FFCP PHASE1:Hg19::chrX:109564494..109564506,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(8 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{{FFCP | {{FFCP | ||
|DHSsupport=supported | |||
|DPIdataset=robust | |||
|EntrezGene=NA | |EntrezGene=NA | ||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=no_gencodeV16_or_build2_transcript | |||
|HGNC=NA | |HGNC=NA | ||
|TSSclassifier=strong | |||
|UniProt=NA | |UniProt=NA | ||
|association_with_transcript=NA | |association_with_transcript=NA | ||
|cluster_id=chrX:109564494..109564506,- | |||
|coexpression_cluster_id=C370 | |||
|description=CAGE_peak_at_chrX:109564494..109564506,- | |description=CAGE_peak_at_chrX:109564494..109564506,- | ||
|id=chrX:109564494..109564506,- | |id=chrX:109564494..109564506,- | ||
|ontology_enrichment_celltype=CL:0000764!1.34e-40!2;CL:0000765!1.34e-40!2;CL:0000050!1.34e-40!2;CL:0000038!1.34e-40!2;CL:0000558!1.34e-40!2;CL:0000547!1.34e-40!2;CL:0000549!1.34e-40!2;CL:0000550!1.34e-40!2;CL:0000552!1.34e-40!2;CL:0002032!2.95e-09!165;CL:0000837!2.95e-09!165;CL:0000037!7.35e-09!172;CL:0000566!7.35e-09!172;CL:0000988!2.40e-08!182;CL:0000817!8.29e-08!3 | |ontology_enrichment_celltype=CL:0000764!1.34e-40!2;CL:0000765!1.34e-40!2;CL:0000050!1.34e-40!2;CL:0000038!1.34e-40!2;CL:0000558!1.34e-40!2;CL:0000547!1.34e-40!2;CL:0000549!1.34e-40!2;CL:0000550!1.34e-40!2;CL:0000552!1.34e-40!2;CL:0002032!2.95e-09!165;CL:0000837!2.95e-09!165;CL:0000037!7.35e-09!172;CL:0000566!7.35e-09!172;CL:0000988!2.40e-08!182;CL:0000817!8.29e-08!3 | ||
|ontology_enrichment_celltype_v019=CL:0000764;1.16e-78;2!CL:0000558;1.16e-78;2 | |||
|ontology_enrichment_celltype_v019_2=CL:0000764,1.16e-78,2;CL:0000765,1.16e-78,2;CL:0000050,1.16e-78,2;CL:0000038,1.16e-78,2;CL:0000558,1.16e-78,2;CL:0000547,1.16e-78,2;CL:0000549,1.16e-78,2;CL:0000550,1.16e-78,2;CL:0000552,1.16e-78,2;CL:0000763,1.03e-09,108;CL:0000049,1.03e-09,108 | |||
|ontology_enrichment_development_v019= | |||
|ontology_enrichment_disease=DOID:8552!1.88e-21!1;DOID:12603!7.72e-21!1;DOID:2531!8.15e-19!51;DOID:0060083!8.15e-19!51;DOID:1240!3.10e-18!39;DOID:1036!6.61e-11!8;DOID:8692!1.04e-10!31;DOID:0050686!8.79e-07!137 | |||
|ontology_enrichment_disease_v019=DOID:8552;9.91e-41;1!DOID:8692;4.17e-12;31!DOID:1240;4.14e-08;39 | |||
|ontology_enrichment_disease_v019_2=DOID:8552,9.91e-41,1;DOID:8692,2.30e-12,31;DOID:1240,5.37e-10,39;DOID:2531,8.01e-08,51;DOID:0060083,8.01e-08,51 | |||
|ontology_enrichment_uberon= | |||
|ontology_enrichment_uberon_v019= | |||
|ontology_enrichment_uberon_v019_2= | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.284338464974843,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.263384084775077,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.41185864310528,1.5686127061494,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.185803175125719,0.144269212976445,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7.04935025439248,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.15529204750391,0,0.19606253431774,0,0,3.01979500062719,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.284338464974843,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.263384084775077,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.41185864310528,1.5686127061494,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.185803175125719,0.144269212976445,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7.04935025439248,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.15529204750391,0,0.19606253431774,0,0,3.01979500062719,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | ||
|short_description=p@chrX:109564494..109564506,- | |short_description=p@chrX:109564494..109564506,- | ||
}} | }} |
Latest revision as of 05:01, 1 August 2015
Short description: | p@chrX:109564494..109564506, - |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_at_chrX:109564494..109564506, - |
Coexpression cluster: | C370_acute_chronic_leukemia_CD34_testicular_Mast_H9 |
Association with transcript: | NA |
EntrezGene: | NA |
HGNC: | NA |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
erythroid lineage cell | 1.16e-78 | 2 |
erythroblast | 1.16e-78 | 2 |
megakaryocyte-erythroid progenitor cell | 1.16e-78 | 2 |
erythroid progenitor cell | 1.16e-78 | 2 |
reticulocyte | 1.16e-78 | 2 |
proerythroblast | 1.16e-78 | 2 |
basophilic erythroblast | 1.16e-78 | 2 |
polychromatophilic erythroblast | 1.16e-78 | 2 |
orthochromatic erythroblast | 1.16e-78 | 2 |
myeloid cell | 1.03e-09 | 108 |
common myeloid progenitor | 1.03e-09 | 108 |
Ontology term | p-value | n |
---|---|---|
chronic myeloid leukemia | 9.91e-41 | 1 |
myeloid leukemia | 2.30e-12 | 31 |
leukemia | 5.37e-10 | 39 |
hematologic cancer | 8.01e-08 | 51 |
immune system cancer | 8.01e-08 | 51 |